Avoro Capital Advisors LLC Syndax Pharmaceuticals Inc Transaction History

Avoro Capital Advisors LLC

$6.65 Billion
Q3 2024

A detailed history of Avoro Capital Advisors LLC transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Avoro Capital Advisors LLC holds 3,888,437 shares of SNDX stock, worth $62 Million. This represents 1.13% of its overall portfolio holdings.

Number of Shares

3,888,437

Previous 3,888,437 -0.0%

Holding current value

$62 Million

Previous $79.8 Million 6.23%

% of portfolio

1.13%

Previous 1.09%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$18.82 - $23.79 $6.28 Million - $7.94 Million	-333,785 Reduced 7.91%	3,888,437 $79.8 Million
Q4 2023 Feb 14, 2024	BUY	$11.39 - $21.67 $19 Million - $36.1 Million	1,666,667 Added 65.22%	4,222,222 $91.2 Million
Q3 2023 Nov 14, 2023	SELL	$14.52 - $21.77 $1.37 Million - $2.06 Million	-94,445 Reduced 3.56%	2,555,555 $37.1 Million
Q4 2022 Feb 14, 2023	BUY	$20.64 - $26.24 $8.83 Million - $11.2 Million	427,778 Added 19.25%	2,650,000 $67.4 Million
Q2 2022 Aug 15, 2022	BUY	$13.64 - $19.48 $23,488 - $33,544	1,722 Added 0.08%	2,222,222 $42.8 Million
Q1 2022 May 16, 2022	BUY	$14.84 - $22.15 $675,220 - $1.01 Million	45,500 Added 2.09%	2,220,500 $38.6 Million
Q4 2021 Feb 14, 2022	BUY	$15.23 - $22.47 $9.59 Million - $14.2 Million	630,000 Added 40.78%	2,175,000 $47.6 Million
Q3 2021 Nov 15, 2021	SELL	$13.87 - $19.8 $20.2 Million - $28.8 Million	-1,455,000 Reduced 48.5%	1,545,000 $29.5 Million
Q2 2021 Aug 16, 2021	BUY	$13.42 - $25.18 $6.71 Million - $12.6 Million	500,000 Added 20.0%	3,000,000 $51.5 Million
Q1 2021 May 17, 2021	BUY	$19.28 - $24.59 $39.5 Million - $50.4 Million	2,050,000 Added 455.56%	2,500,000 $55.9 Million
Q4 2020 Feb 16, 2021	BUY	$15.1 - $26.44 $6.8 Million - $11.9 Million	450,000 New	450,000 $10 Million

Others Institutions Holding SNDX

# of Institutions

227

Shares Held

88.3M

Call Options Held

1.01M

Put Options Held

692K

View Full List

About Syndax Pharmaceuticals Inc

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $902M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

More about SNDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Avoro Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avoro Capital Advisors LLC with notifications on news.

Account

Avoro Capital Advisors LLC Syndax Pharmaceuticals Inc Transaction History